Programs
The National Cancer Institute's (NCI) Clinical Proteomic Tumor Analysis Consortium (CPTAC) is composed of three integrated components:
- Proteome Characterization Centers (PCCs)
- Data Coordinating Center
- Resource Center
Click here for a screen reader-friendly version of this graphic.
These components are working in tandem to better understand cancer biology and the protein component of tumor tissue. A key CPTAC partnership is with The Cancer Genome Atlas, where most of the genomically characterized tumor samples originate from. This scientific partnership is providing a link to connect the genome to the proteome. For more information about CPTAC is also available from the downloadable program flyer by clicking here.
Completed Programs
Also additional information regarding previously funded programs and initiatives from the Office of Cancer Clinical Proteomics Research are available:
Launch Antibody Portal »
The Antibody Portal serves as a public resource of monoclonal antibodies made available by the NCI for the scientific community to support protein/peptide measurement and analysis efforts.